The Latest

  • None
    Image attribution tooltip
    Karissa Waddick/PharmaVoice

    #DIA2022: Building 'guardrails' in the FDA's accelerated approval program

    Regulatory experts weigh in on ways to enhance the controversial drug approval approach.

  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Kronos Bio's Barbara Kosacz

    Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.

  • Chicago skyline
    Image attribution tooltip
    Michael Gibney/PharmaVoice

    #DIA2022: How the industry's top regulator views the future of healthcare

    In the evolution of healthcare, data is the linchpin to making drug development more efficient.

  • A person in a white doctors coat and stethoscope holds up a magnifying glass.
    Image attribution tooltip
    Valiantsin Suprunovich via Getty Images

    The public health sleuth

    In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.

  • schizophrenia
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech spotlight: Karuna Therapeutics' mission to rejuvenate the field of neuroscience

    An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.

  • Boy in wheelchair
    Image attribution tooltip
    ChiccoDodiFC via Getty Images

    A patient-funded ALS drug offers hope where few treatments exist

    Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.

  • Image attribution tooltip
    Drew Angerer / Staff via Getty Images

    TikTok tutorial: How pharma can embrace the video platform's educational potential

    Ogilvy Health’s director of social strategy, Katie Ferrigno, busts myths and provides tips on how biopharmas can take advantage of TikTok’s unique features to connect with patients.

  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Tango Therapeutics' Dr. Barbara Weber

    A pioneer in genetic medicine, Dr. Barbara Weber continues to push the envelope to expand the reach of therapies based on genetic targeting.

  • Image attribution tooltip
    Michael Ciaglo / Stringer via Getty Images
    Profile

    Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching

    Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.

  • Scientist pipetting sample into a multi well plate
    Image attribution tooltip
    iStock via Getty Images
    Q&A

    Why biomanufacturing is the next innovation frontier for genomic therapies

    While cell and gene therapy research has accelerated quickly, manufacturing in the space hasn’t quite kept up, Danaher’s Chief Science Officer JC Gutiérrez-Ramos says.

  • Editas Medicine CEO Gilmore O'Neill
    Image attribution tooltip
    Permission granted by Editas/Gilmore O'Neill
    Q&A

    First 90 Days: Editas Medicine's Gilmore O'Neill

    The first-time CEO is flexing new muscles as he steers the gene editing company through clinical trials and beyond.

  • A male wooden figure climbs steps of a ladder.
    Image attribution tooltip
    iStock via Getty Images

    Making moves: Civica, Astellas, Inozyme and more announce key new hires

    The latest hiring moves from Civica, Astella, Inozyme and the Flagship Pioneering-founded Tessera Therapeutics. 

  • brain drug
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    A combo of precision meds and diagnostics could disrupt mental healthcare

    HMNC Brain Health, a clinical-stage company, is leveraging cutting-edge tech to offer a new approach to mental health challenges.

  • Merck director of clinical trial patient diversity Adrelia Allen
    Image attribution tooltip
    Permission granted by Merck/Adrelia Allen

    As cancer innovations thrive, patient access is the next piece of the puzzle

    Why enhanced clinical trials and diagnostics are keys to boosting patient access to cancer care.

  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Janssen's Najat Khan

    Janssen’s Najat Khan, Ph.D., chief data science officer and global head of strategy and operations, shares how the company is using next-gen tech to ‘reimagine’ medicine.

  • The sun rises over the rural, Tennessee mountain town of Gatlinburg.
    Image attribution tooltip
    Jonathan Ross via Getty Images

    Pharma giants take on Appalachian cancer rates in newest screening initiative

    AstraZeneca and Bristol Myers Squibb are teaming up with the nonprofit Association of Community Cancer Centers to increase lung cancer screening in rural Appalachia for the long haul.

  • drug development
    Image attribution tooltip
    Stock via Getty Images
    Profile

    After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

    The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.

  • Merck senior vice president of early stage development in clinical oncology Eric Rubin
    Image attribution tooltip
    Permission granted by Merck/Eric Rubin

    How to build a cancer pipeline: Big Pharma oncology heads on driving science forward

    Executives leading the cancer departments at J&J, Merck and Takeda chime in on what it takes to construct a successful and sustainable oncology drug pipeline.

  • David Jimenez
    Image attribution tooltip

    Permission granted by David Jimenez.

    Q&A

    First 90 Days: Janssen Immunology's David Jimenez

    The long-time company man discusses the mega-drugmaker’s plans for growth and why, if you meet with him, you should plan on sipping coffee.

  • Medicare enrollment form and money.
    Image attribution tooltip
    iStock via Getty Images

    Aduhelm's Medicare woes leave questions about lofty premiums

    A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.

  • Avak Kahvejian
    Image attribution tooltip

    Permission granted by Flagship Pioneering/Avak Kahvejian.

    Profile

    Flagship's creative approach to finding the next big idea in biopharma

    Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

  • Colorful DNA double helix.
    Image attribution tooltip
    iStock via Getty Images

    Cell and gene therapy advances coming fast and furious

    A peek into R&D at the Mass General Brigham network reveals up-and-coming treatments pushing the boundaries of what’s possible in medicine.

  • Kerrie Brady head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: OcuTerra Therapeutics' Kerrie Brady

    The serial entrepreneur and now head of OcuTerra explains why taking risks in pharma pays off.

  • Monkeypox test
    Image attribution tooltip
    Stock via Getty Images

    SIGA prepares to kick production for monkeypox treatment into high gear

    ‘We’re not bored,’ the company’s science chief says as SIGA Technologies looks to ramp up supplies of its therapeutic.

  • Sosei Heptares CEO Chris Cargill
    Image attribution tooltip
    Permission granted by Sosei Heptares/Chris Cargill
    Q&A

    First 90 Days: Sosei Heptares' Chris Cargill

    The company’s new CEO is looking to drive growth through collaboration and transparency.